Vischini, Gisella
 Distribuzione geografica
Continente #
NA - Nord America 229
EU - Europa 201
AS - Asia 58
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 500
Nazione #
US - Stati Uniti d'America 228
SE - Svezia 59
DE - Germania 38
CN - Cina 35
FR - Francia 35
PL - Polonia 32
IE - Irlanda 11
SG - Singapore 10
IN - India 9
CI - Costa d'Avorio 8
IT - Italia 8
UA - Ucraina 6
RU - Federazione Russa 4
FI - Finlandia 3
GB - Regno Unito 2
IR - Iran 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
NO - Norvegia 1
Totale 500
Città #
Chandler 71
Kraków 32
Ashburn 16
Ann Arbor 11
Dublin 11
New York 11
Nanjing 10
Abidjan 8
Wilmington 8
Bremen 7
Marseille 6
Princeton 6
San Mateo 6
Dearborn 5
Jacksonville 5
Singapore 5
Boston 4
Fairfield 4
Beijing 3
Cattolica 3
Augusta 2
Changchun 2
Izmir 2
Lawrence 2
Moscow 2
Mountain View 2
Seattle 2
Woodbridge 2
Zhengzhou 2
Bern 1
Boardman 1
Brussels 1
Chicago 1
Ergolding 1
Guangzhou 1
Hangzhou 1
Hebei 1
Helsinki 1
Kemerovo 1
Kish 1
Los Angeles 1
Munich 1
Nanchang 1
Oslo 1
Redwood City 1
Rome 1
San Francisco 1
Stockholm 1
São Paulo 1
Toronto 1
Wuhan 1
Totale 272
Nome #
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 134
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury 82
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura 61
SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis 50
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 49
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 46
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 45
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report 42
Totale 509
Categoria #
all - tutte 2.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 8 4 2 4 1 2 6 0 4 2 8 3
2020/202119 0 2 0 2 1 0 6 0 1 1 3 3
2021/202270 7 2 1 1 6 2 0 13 4 4 16 14
2022/2023206 26 25 12 34 10 25 17 19 32 0 5 1
2023/202464 4 16 1 8 0 6 4 1 0 2 12 10
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 509